Lanean...
Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy
OBJECTIVE: To evaluate the cost-effectiveness of nusinersen with and without universal newborn screening for infantile-onset spinal muscular atrophy (SMA). STUDY DESIGN: Markov model using data from clinical trials with U.S. epidemiologic and cost data was developed. Primary interventions studied we...
Gorde:
| Argitaratua izan da: | J Pediatr |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686158/ https://ncbi.nlm.nih.gov/pubmed/32659229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2020.07.033 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|